|
Market Closed -
Japan Exchange
10:30:00 11/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 2,320.00 JPY | -1.00% |
|
-5.25% | +6.79% |
| 09-02 | Ono Pharmaceutical Co., Ltd. Enters Into Drug Discovery Partnership With Aitia, Inc | CI |
| 07-31 | Ono Pharmaceutical's Profit Rises 37% in Fiscal Q1 | MT |
| Market Cap | 1,090B 7.1B 6.12B 5.79B 5.25B 9.85B 678B 9.9B 68.78B 26.45B 345B 26.66B 26.07B | P/E 2027 * |
15x | P/E 2028 * | 17.3x |
|---|---|---|---|---|---|
| Enterprise Value | 889B 5.79B 4.99B 4.72B 4.28B 8.03B 553B 8.07B 56.09B 21.57B 281B 21.74B 21.26B | EV / Sales 2027 * |
1.94x | EV / Sales 2028 * | 1.87x |
| Free-Float |
81.92% | Yield 2027 * |
3.37% | Yield 2028 * | 3.33% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 4528 | Delayed | |
OTC Markets
| OPHLF | Delayed | |
|
Deutsche Boerse AG
| ON4 | Delayed | |
|
Börse Stuttgart
| ON4 | Delayed | |
|
Boerse Muenchen
| ON4 | Real-time | |
|
Tradegate
| ON4 | Real-time |
Last Transcript : Ono Pharmaceutical Co., Ltd.
| 1 day | -1.00% | ||
| 1 week | -5.25% | ||
| Current month | -5.33% | ||
| 1 month | -3.97% | ||
| 3 months | +4.86% | ||
| 6 months | -0.66% | ||
| Current year | +6.79% |
| 1 week | 2,290.5 |  | 2,452 |
| 1 month | 2,290.5 | | 2,517.5 |
| Current year | 2,114.5 | | 2,674.5 |
| 1 year | 1,674 | | 2,674.5 |
| 3 years | 1,474 | | 2,966.5 |
| 5 years | 1,474 | | 3,990 |
| 10 years | 1,474 | | 3,990 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CEO | Chief Executive Officer | 67 | 01/04/2024 |
Masaki Ito
DFI | Director of Finance/CFO | - | 01/04/2026 |
Toichi Takino
PSD | President | 57 | 01/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CHM | Chairman | 67 | 01/04/2024 |
Toichi Takino
BRD | Director/Board Member | 57 | 01/06/2020 |
Masao Nomura
BRD | Director/Board Member | 77 | 26/06/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.00% | -5.25% | +34.34% | -19.63% | 7.1B | |
| -1.13% | -3.11% | +13.82% | +60.66% | 46.21B | |
| -1.13% | -5.78% | +33.26% | +108.13% | 38.78B | |
| +0.12% | -0.08% | +7.12% | +78.27% | 11.68B | |
| -0.53% | -1.37% | -13.25% | +10.18% | 11.55B | |
| -0.38% | -2.26% | +18.18% | +139.63% | 9.14B | |
| +0.32% | -2.26% | +23.08% | +34.73% | 7.3B | |
| +0.17% | -0.74% | +13.44% | +197.13% | 7.15B | |
| -3.13% | -4.30% | -44.88% | +11.66% | 4.97B | |
| +0.38% | +1.98% | +37.00% | +105.95% | 4.62B | |
| Average | -0.63% | -2.14% | +12.21% | +72.67% | 14.85B | |
| Weighted average by Cap. | -0.82% | -3.11% | +16.71% | +76.60% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 458B 2.99B 2.57B 2.44B 2.21B 4.14B 285B 4.16B 28.92B 11.12B 145B 11.21B 10.97B | 448B 2.92B 2.52B 2.38B 2.16B 4.05B 279B 4.07B 28.29B 10.88B 142B 10.97B 10.73B |
| Net income | 72.89B 475M 409M 387M 351M 658M 45.34B 662M 4.6B 1.77B 23.07B 1.78B 1.74B | 63.15B 411M 354M 335M 304M 570M 39.28B 573M 3.98B 1.53B 19.99B 1.54B 1.51B |
| Net Debt | -201B -1.31B -1.13B -1.07B -968M -1.82B -125B -1.83B -12.69B -4.88B -63.64B -4.92B -4.81B | -250B -1.63B -1.4B -1.33B -1.2B -2.26B -155B -2.27B -15.75B -6.06B -79.02B -6.11B -5.97B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/09/26 | ¥2,320.00 | -1.00% | 1,647,400 |
| 10/09/26 | ¥2,343.50 | -0.40% | 1,150,900 |
| 09/09/26 | ¥2,353.00 | -2.95% | 1,354,600 |
| 08/09/26 | ¥2,424.50 | +0.25% | 1,218,900 |
| 07/09/26 | ¥2,418.50 | -1.23% | 1,201,300 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4528 Stock
Select your edition
All financial news and data tailored to specific country editions
